Literature DB >> 18813824

Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.

Eric Roman1, Leonardo A Meza-Zepeda, Stine H Kresse, Ola Myklebost, Endre N Vasstrand, Salah O Ibrahim.   

Abstract

We used microarray-based comparative genomic hybridization to explore genome-wide profiles of chromosomal aberrations in 26 samples of head and neck cancers compared to their pair-wise normal controls. The samples were obtained from Sudanese (n=11) and Norwegian (n=15) patients. The findings were correlated with clinicopathological variables. We identified the amplification of 41 common chromosomal regions (harboring 149 candidate genes) and the deletion of 22 (28 candidate genes). Predominant chromosomal alterations that were observed included high-level amplification at 1q21 (harboring the S100A gene family) and 11q22 (including several MMP family members). Regions of copy number increase was also identified at 6p21 (p21), 7p12 (EGFR), 17p13 (p53) and 19p13.2 (p19INK4d), while regions showing deletion included among others 3p25.2 (RAF1) and 9p21 (p15, p16). We found genes from four common biological pathways (MAPK signaling, cytokine-cytokine receptor interaction, ECM-receptor interaction and Jak-STAT signaling) to be predominantly over-represented in areas of gain and loss. The current study provides valuable information on chromosomal aberrations likely to be involved in the pathogenesis of head and neck cancers. An increased copy number of the S100A and MMP gene family members, known to be involved in invasion and metastasis, may play an important role in the development of the tumors. Hierarchical clustering of the chromosomal alterations with clinicopathological parameters showed little correlation, suggesting an occurrence of gains/losses regardless of ethnic differences and clinicopathological status between the patients from the two countries. Our findings indicate the existence of common gene-specific amplifications/deletions in these tumors, regardless of the source of the samples or attributed carcinogenic risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18813824

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases.

Authors:  Jie Yang; Donna McEachern; Wenyan Li; Mary A Davis; Hua Li; Meredith A Morgan; Longchuan Bai; Jonathan T Sebolt; Haiying Sun; Theodore S Lawrence; Shaomeng Wang; Yi Sun
Journal:  Mol Cancer Ther       Date:  2011-01-31       Impact factor: 6.261

2.  Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.

Authors:  Mohammed Taoudi Benchekroun; Pierre Saintigny; Sufi M Thomas; Adel K El-Naggar; Vassiliki Papadimitrakopoulou; Hening Ren; Wenhua Lang; You-Hong Fan; Jianhua Huang; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Faye M Johnson; Jennifer R Grandis; Li Mao
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-22

3.  A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.

Authors:  Xu Guo; Xi Ma; Jiaze An; Yukui Shang; Qichao Huang; Hushan Yang; Zhinan Chen; Jinliang Xing
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

Review 4.  The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.

Authors:  Steven F Powell; Lexi Vu; William C Spanos; Dohun Pyeon
Journal:  Cancers (Basel)       Date:  2021-10-17       Impact factor: 6.575

Review 5.  Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies.

Authors:  Araceli Diez-Fraile; Joke De Ceulaer; Charlotte Derpoorter; Christophe Spaas; Tom De Backer; Philippe Lamoral; Johan Abeloos; Tim Lammens
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

6.  Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas.

Authors:  Sandra Bernaldo de Quirós; Anna Merlo; Pablo Secades; Iriana Zambrano; Ines Saenz de Santa María; Nerea Ugidos; Eloisa Jantus-Lewintre; Rafael Sirera; Carlos Suarez; María-Dolores Chiara
Journal:  BMC Cancer       Date:  2013-03-14       Impact factor: 4.430

7.  YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.

Authors:  Erica Lorenzetto; Monica Brenca; Mattia Boeri; Carla Verri; Elena Piccinin; Patrizia Gasparini; Federica Facchinetti; Sabrina Rossi; Giuliana Salvatore; Maura Massimino; Gabriella Sozzi; Roberta Maestro; Piergiorgio Modena
Journal:  Oncotarget       Date:  2014-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.